DR5 related autophagy can promote apoptosis in gliomas after irradiation

Peng Zhang1, Hailong Wang1, Yu Chen1

  • 1School of Life Science, Beijing Institute of Technology, Beijing, 100081, China.

Insights

Irradiation therapy enhances cancer cell death via the death receptor 5 (DR5) pathway. DR5 interacts with autophagy proteins and Caspase8, promoting apoptosis in gliomas and suggesting a new glioblastoma treatment strategy.

Area of Science:

  • Oncology
  • Cell Biology
  • Cancer Therapeutics

Background:

  • Irradiation therapy is a common cancer treatment causing DNA damage and cell death, primarily apoptosis and autophagy.
  • The interplay between apoptosis and autophagy in response to irradiation remains incompletely understood at the molecular level.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which autophagy influences apoptosis in gliomas following irradiation.
  • To investigate the role of death receptor 5 (DR5) in mediating the effects of autophagy on irradiation-induced apoptosis.

Main Methods:

  • Investigated the interaction between DR5, LC3B, and Caspase8 in glioma cells after irradiation.
  • Utilized four autophagy inducers (rapamycin, CCI779, ABT737, temozolomide) to assess their effects on DR5 expression and apoptosis.

Main Results:

  • Apoptosis was enhanced by the DR5 pathway, with DR5 interacting with LC3B and Caspase8 to promote autophagy's effect on apoptosis in irradiated gliomas.
  • ABT737 and temozolomide increased DR5 expression and cell death, unlike rapamycin and CCI779.

Conclusions:

  • DR5 plays a critical role in promoting irradiation-induced apoptosis.
  • DR5 targeting represents a potential therapeutic strategy for glioblastoma treatment.